789
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Antigen profiling analysis of vaccinia virus injected canine tumors

Oncolytic virus efficiency predicted by boolean models

, , , , &
Pages 319-325 | Received 13 May 2014, Accepted 31 Jul 2014, Published online: 31 Jul 2014

References

  • Merlo DF, Rossi L, Pellegrino C, Ceppi M, Cardellino U, Capurro C, Ratto A, Sambucco PL, Sestito V, Tanara G, et al. Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy. J Vet Intern Med 2008; 22:976 - 84; http://dx.doi.org/10.1111/j.1939-1676.2008.0133.x; PMID: 18564221
  • Dorn ER. Epidemiology of canine and feline tumors. J Am Anim Hosp Assoc 1976; 12:307 - 12
  • Gobar GM, Case JT, Kass PH. Program for surveillance of causes of death of dogs, using the Internet to survey small animal veterinarians. J Am Vet Med Assoc 1998; 213:251 - 6; PMID: 9676598
  • Bronson RT. Variation in age at death of dogs of different sexes and breeds. Am J Vet Res 1982; 43:2057 - 9; PMID: 6891194
  • Foundation MA. In Companion Animal News, Animal Health Survey. Morris Animal Foundation 1998, 2005.
  • Kelsey JL, Moore AS, Glickman LT. Epidemiologic studies of risk factors for cancer in pet dogs. Epidemiol Rev 1998; 20:204 - 17; http://dx.doi.org/10.1093/oxfordjournals.epirev.a017981; PMID: 9919439
  • Patil SS, Gentschev I, Nolte I, Ogilvie G, Szalay AA. Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients. J Transl Med 2012; 10:3; http://dx.doi.org/10.1186/1479-5876-10-3; PMID: 22216938
  • Gentschev I, Patil SS, Petrov I, Cappello J, Adelfinger M, Szalay AA. Oncolytic virotherapy of canine and feline cancer. Viruses 2014; 6:2122 - 37; http://dx.doi.org/10.3390/v6052122; PMID: 24841386
  • Whilding LM, Archibald KM, Kulbe H, Balkwill FR, Öberg D, McNeish IA. Vaccinia virus induces programmed necrosis in ovarian cancer cells. Mol Ther 2013; 21:2074 - 86; http://dx.doi.org/10.1038/mt.2013.195; PMID: 23985697
  • Patil SS, Gentschev I, Adelfinger M, Donat U, Hess M, Weibel S, Nolte I, Frentzen A, Szalay AA. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody. PLoS One 2012; 7:e47472; http://dx.doi.org/10.1371/journal.pone.0047472; PMID: 23091626
  • Chen NG, Yu YA, Zhang Q, Szalay AA. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice. J Transl Med 2011; 9:164; http://dx.doi.org/10.1186/1479-5876-9-164; PMID: 21951588
  • Gentschev I, Donat U, Hofmann E, Weibel S, Adelfinger M, Raab V, Heisig M, Chen N, Yu YA, Stritzker J, et al. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68. J Biomed Biotechnol 2010; 2010:489759; http://dx.doi.org/10.1155/2010/489759; PMID: 20379368
  • Gentschev I, Adelfinger M, Josupeit R, Rudolph S, Ehrig K, Donat U, Weibel S, Chen NG, Yu YA, Zhang Q, et al. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma. PLoS One 2012; 7:e37239; http://dx.doi.org/10.1371/journal.pone.0037239; PMID: 22615950
  • Gentschev I, Stritzker J, Hofmann E, Weibel S, Yu YA, Chen N, Zhang Q, Bullerdiek J, Nolte I, Szalay AA. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Cancer Gene Ther 2009; 16:320 - 8; http://dx.doi.org/10.1038/cgt.2008.87; PMID: 18949014
  • Gentschev I, Ehrig K, Donat U, Hess M, Rudolph S, Chen N, Yu YA, Zhang Q, Bullerdiek J, Nolte I, et al. Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68. J Oncol 2010; 2010:736907; http://dx.doi.org/10.1155/2010/736907; PMID: 20631910
  • Fork MA, Murua Escobar H, Soller JT, Sterenczak KA, Willenbrock S, Winkler S, Dorsch M, Reimann-Berg N, Hedrich HJ, Bullerdiek J, et al. Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258. BMC Cancer 2008; 8:240; http://dx.doi.org/10.1186/1471-2407-8-240; PMID: 18706092
  • Moulay M, Liu W, Willenbrock S, Sterenczak KA, Carlson R, Ngezahayo A, Murua Escobar H, Nolte I. Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines. Anticancer Res 2013; 33:5421 - 31; PMID: 24324078
  • Gentschev I, Patil SS, Adelfinger M, Weibel S, Geissinger U, Frentzen A, Chen NG, Yu YA, Zhang Q, Ogilvie G, et al. Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy. Bioengineered 2013; 4:84 - 9; http://dx.doi.org/10.4161/bioe.22462; PMID: 23093804
  • Advani SJ, Buckel L, Chen NG, Scanderbeg DJ, Geissinger U, Zhang Q, Yu YA, Aguilar RJ, Mundt AJ, Szalay AA. Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenografts. Clin Cancer Res 2012; 18:2579 - 90; http://dx.doi.org/10.1158/1078-0432.CCR-11-2394; PMID: 22379115
  • Zhang Q, Yu YA, Wang E, Chen N, Danner RL, Munson PJ, Marincola FM, Szalay AA. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res 2007; 67:10038 - 46; http://dx.doi.org/10.1158/0008-5472.CAN-07-0146; PMID: 17942938
  • Harlan Laboratories [Internet]. Maasheseweg 87c, Venray 5804 AB, Netherlands: Hsd: Athymic Nude-Foxn1nu mice; c2014 [cited 2014 May 15]. Available from: http://www.harlan.com
  • Funahashi A, Matsuoka Y, Jouraku A, Morohashi M, Kikuchi N, Kitano H. CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks. Proc IEEE 2008; 96:1254 - 65; http://dx.doi.org/10.1109/JPROC.2008.925458
  • yWorks GmbH [Internet]. Vor dem Kreuzberg 28, 72070 Tübingen, Germany: yED Graph Editor, Version 3.11.; c2014 [cited 2014 May 15]. Available from: http://www.yworks.com/en/products_yed_about.html
  • Di Cara A, Garg A, De Micheli G, Xenarios I, Mendoza L. Dynamic simulation of regulatory networks using SQUAD. BMC Bioinformatics 2007; 8:462; http://dx.doi.org/10.1186/1471-2105-8-462; PMID: 18039375

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.